Literature DB >> 33559865

Evaluation of carcinogenic activities and sperm abnormalities of Gram-negative bacterial metabolites isolated from cancer patients after subcutaneous injection in albino rats.

Mervat Morsy Abbas Ahmed El-Gendy1, Khaled G Abdel-Wahhab2, Nabila S Hassan3, Esraa Ahmed El-Bondkly4, Ayman A Farghaly5, Hanan F Ali6, Sanaa A Ali6, Ahmed M A El-Bondkly5.   

Abstract

Microbial pathogens drive tumorigenesis in 20% of cancer cases, so the present study is aimed to evaluate the carcinogenic activities, sperm abnormalities and other dangerous effects of the subcutaneous injection of extracts obtained from various clinical Gram-negative bacteria derived from cancer patients using albino rats. We isolated, identified and extracted of their secondary metabolites of carbapenem resistant Gram-negative bacteria derived from cancer patients. Various methods have been used to determine hepatotoxicity, nephrotoxicity, tumorigenesis, inflammatory and sperm abnormalities in the albino rats injected with extracts. In comparison with the normal animals group, all extracts induced hepatotoxicity which was evidenced by the significant elevation in the activity of the serum alanine aminotransferase, aspartate aminotransferase, gamma-glutamyltransferase and alkaline phosphatase; also, nephrotoxicity that was indicated through the marked increase in the serum urea and creatinine levels; tumorigenesis was achieved from the sharp elevation in serum levels of alpha fetoprotein, carcinoembryonic antigen and lactate dehydrogenase values as tumor markers; as well as severe inflammatory characteristics were monitored from the marked raise of tumor necrosis factor alpha and interleukin-1beta. Furthermore, the proportion of micronuclei in polychromatic erythrocytes and sperm abnormalities were statistically significant in all groups compared to control group. Various kinds of head abnormalities and coiled tail were noted. Histopathological examination of hepatic tissue came in line with the biochemical and cytological findings. It could conclude that the extracts of Serratia sp. Esraa 1, Stenotrophomonas sp. Esraa 2, Acinetobacter sp. Esraa 3, Escherichia sp. Esraa 4 and Pseudomonas sp. Esraa 5 were able to initiate cytotoxicity and tumorigenesis in rats.

Entities:  

Keywords:  Carcinogenesis; Hepatotoxicity; Multidrug resistance bacteria; Nephrotoxicity; Sperm anomalies

Year:  2021        PMID: 33559865     DOI: 10.1007/s10482-021-01522-w

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  5 in total

1.  Estimation of the number of nucleotide substitutions when there are strong transition-transversion and G+C-content biases.

Authors:  K Tamura
Journal:  Mol Biol Evol       Date:  1992-07       Impact factor: 16.240

2.  A probability matrix for the identification of gram-negative, aerobic, non-fermentative bacteria that grow on nutrient agar.

Authors:  B Holmes; C A Pinning; C A Dawson
Journal:  J Gen Microbiol       Date:  1986-07

3.  m6A mRNA methylation regulates CTNNB1 to promote the proliferation of hepatoblastoma.

Authors:  Li Liu; Jing Wang; Guifeng Sun; Qiong Wu; Ji Ma; Xin Zhang; Nan Huang; Zhixuan Bian; Song Gu; Min Xu; Minzhi Yin; Fenyong Sun; Qiuhui Pan
Journal:  Mol Cancer       Date:  2019-12-23       Impact factor: 27.401

4.  Colibactin DNA-damage signature indicates mutational impact in colorectal cancer.

Authors:  Paulina J Dziubańska-Kusibab; Hilmar Berger; Federica Battistini; Britta A M Bouwman; Amina Iftekhar; Riku Katainen; Tatiana Cajuso; Nicola Crosetto; Modesto Orozco; Lauri A Aaltonen; Thomas F Meyer
Journal:  Nat Med       Date:  2020-06-01       Impact factor: 53.440

5.  Real-World Scenario of Patients With Lung Cancer Amid the Coronavirus Disease 2019 Pandemic in the People's Republic of China.

Authors:  Rui Fu; Lin Wu; Chao Zhang; Qian Chu; Jie Hu; Gen Lin; Lin Yang; Ji-Sheng Li; Xue-Ning Yang; Jin-Ji Yang; Qing Zhou; Yi-Long Wu; Wen-Zhao Zhong
Journal:  JTO Clin Res Rep       Date:  2020-05-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.